Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing the previous v3.6.2. This indicates a page version update without altering the study content visible to users.
    Difference
    0.0%
    Check dated 2026-07-07T03:00:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2. This denotes a small CMS/page update rather than a substantive change to the study details or content.
    Difference
    0.0%
    Check dated 2026-06-29T17:30:55.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    New sections How to Read a Study Record, Common Questions, and How to Join a Study have been added, and a note indicates no participants are currently being recruited. The Intervention/Treatment header formatting was adjusted and the revision label updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T08:44:30.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s revision history now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This updates the revision record without altering the study details.
    Difference
    0.0%
    Check dated 2026-06-08T04:38:18.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page's revision/version label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page version.
    Difference
    0.0%
    Check dated 2026-05-17T10:40:11.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page’s footer now shows a newer site “Revision” version (v3.5.3 instead of v3.5.2), indicating a ClinicalTrials.gov site software update.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.